GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call

GDRX 10.10.2024

Full Press ReleaseSEC FilingsOur GDRX Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Scott Wagner Joins GoodRx Board of Directors
  • 01.21.2025 - Steven Valiquette
  • 01.15.2025 - Wendy Barnes

Recent Filings

  • 01.22.2025 - 8-K Current report
  • 01.15.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.08.2025 - 3 Initial statement of beneficial ownership of securities
PDF Version

SANTA MONICA, Calif.--(BUSINESS WIRE)--Oct. 10, 2024--GoodRx Holdings, Inc.(Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in theU.S., today announced it will release its third quarter 2024 financial results beforeU.S.markets open onThursday, November 7, 2024.GoodRxmanagement will also hold a conference call and webcast that morning at5:00 a.m. Pacific Time(8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

To access the conference call, please pre-register using thislink. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s investor relations website athttps://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.

Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website athttps://investors.goodrx.comfor at least 30 days.

AboutGoodRx

GoodRxis the leading prescription savings platform in theU.S.Trusted by more than 25 million consumers and 750,000 healthcare professionals annually,GoodRxprovides access to savings and affordability options for generic and brand-name medications at more than 70,000 pharmacies nationwide, as well as comprehensive healthcare research and information. Since 2011,GoodRxhas helped consumers save over$75 billionon the cost of their prescriptions.

GoodRxperiodically posts information that may be important to investors on its investor relations website athttps://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with theSecurities and Exchange Commissionand public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241010574999/en/

Investor ContactGoodRxAubrey Reynoldsir@goodrx.comMedia ContactGoodRxLauren Casparislcasparis@goodrx.com

Source:GoodRx Holdings, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com